Quarterly report pursuant to Section 13 or 15(d)

Operating Segments (Tables)

v3.20.1
Operating Segments (Tables)
3 Months Ended
Mar. 31, 2020
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information

The table below presents certain financial information of our operating segments for the three months ended March 31, 2020 and 2019 (in thousands):

 

Segment Reporting for the Quarter Ended March 31, 2020

 

    Treatment     Services     Medical     Segments Total     Corporate(1)     Consolidated Total  
Revenue from external customers   $ 9,563     $ 15,297       —     $ 24,860     $ —     $ 24,860  
Intercompany revenues     207       8       —       215       —       —  
Gross profit     2,745       1,895       —       4,640       —       4,640  
Research and development     94       66       66       226       6       232  
Interest income     —       —       —       —       56       56  
Interest expense     (18 )     (6 )     —       (24 )     (96 )     (120 )
Interest expense-financing fees     —       —       —       —       (68 )     (68 )
Depreciation and amortization     264       77       —       341       5       346  
Segment income (loss) before income taxes     1,547       1,318       (66 )     2,799       (1,477 )     1,322  
Income tax expense     (14 )     —       —       (14 )     —       (14 )
Segment income (loss)     1,533       1,318       (66 )     2,785       (1,477 )     1,308  
Expenditures for segment assets     679       214       —       893       3       896 (2)

 

Segment Reporting for the Quarter Ended March 31, 2019

 

    Treatment     Services     Medical     Segments Total     Corporate(1)     Consolidated Total  
Revenue from external customers   $ 9,905     $ 1,803       —     $ 11,708     $ —     $ 11,708  
Intercompany revenues     2       21       —       23       —       —  
Gross profit/(negative) gross profit     2,957       (456 )     —       2,501       —       2,501  
Research and development     147       —       74       221       6       227  
Interest income     —       —       —       —       81       81  
Interest expense     (17 )     (9 )     —       (26 )     (61 )     (87 )
Interest expense-financing fees     —       —       —       —       (10 )     (10 )
Depreciation and amortization     237       78       —       315       8       323  
Segment income (loss) before income taxes     1,875       (1,012 )     (74 )     789       (1,300 )     (511 )
Income tax expense     (39 )     —       —       (39 )     —       (39 )
Segment income (loss)     1,836       (1,012 )     (74 )     750       (1,300 )     (550 )
Expenditures for segment assets     222       2       —       224       —       224 (2)

 

(1) Amounts reflect the activity for corporate headquarters not included in the segment information.

 

(2) Net of financed amount of $82,000 and $4,000 for the three month ended March 31, 2020 and 2019, respectively.